Follow
James Leverenz
James Leverenz
Verified email at ccf.org
Title
Cited by
Cited by
Year
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
IG McKeith, BF Boeve, DW Dickson, G Halliday, JP Taylor, D Weintraub, ...
Neurology 89 (1), 88-100, 2017
33472017
Genetic meta-analysis of diagnosed Alzheimerís disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ...
Nature genetics 51 (3), 414-430, 2019
21662019
Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature
PT Nelson, I Alafuzoff, EH Bigio, C Bouras, H Braak, NJ Cairns, ...
Journal of Neuropathology & Experimental Neurology 71 (5), 362-381, 2012
21222012
The Parkinson progression marker initiative (PPMI)
K Marek, D Jennings, S Lasch, A Siderowf, C Tanner, T Simuni, C Coffey, ...
Progress in neurobiology 95 (4), 629-635, 2011
14832011
Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial
S Craft, LD Baker, TJ Montine, S Minoshima, GS Watson, A Claxton, ...
Archives of neurology 69 (1), 29-38, 2012
13722012
Analysis of shared heritability in common disorders of the brain
Brainstorm Consortium, V Anttila, B Bulik-Sullivan, HK Finucane, ...
Science 360 (6395), eaap8757, 2018
13622018
Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria
DW Dickson, H Braak, JE Duda, C Duyckaerts, T Gasser, GM Halliday, ...
The Lancet Neurology 8 (12), 1150-1157, 2009
11072009
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ...
Nature genetics 49 (9), 1373-1384, 2017
8972017
TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis
VM Van Deerlin, JB Leverenz, LM Bekris, TD Bird, W Yuan, LB Elman, ...
The Lancet Neurology 7 (5), 409-416, 2008
8612008
DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinsonís disease
Z Hong, M Shi, KA Chung, JF Quinn, ER Peskind, D Galasko, J Jankovic, ...
Brain 133 (3), 713-726, 2010
7252010
TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimerís disease mouse models
TR Jay, CM Miller, PJ Cheng, LC Graham, S Bemiller, ML Broihier, G Xu, ...
Journal of Experimental Medicine 212 (3), 287-295, 2015
6882015
DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers
CF Lippa, JE Duda, M Grossman, HI Hurtig, D Aarsland, BF Boeve, ...
Neurology 68 (11), 812-819, 2007
6802007
Neuropathologic substrates of Parkinson disease dementia
DJ Irwin, MT White, JB Toledo, SX Xie, JL Robinson, V Van Deerlin, ...
Annals of neurology 72 (4), 587-598, 2012
5512012
Clinico‐neuropathological correlation of Alzheimer's disease in a community‐based case series
A Lim, D Tsuang, W Kukull, D Nochlin, J Leverenz, W McCormick, ...
Journal of the American Geriatrics Society 47 (5), 564-569, 1999
5381999
Pathological correlates of dementia in a longitudinal, population‐based sample of aging
JA Sonnen, EB Larson, PK Crane, S Haneuse, G Li, GD Schellenberg, ...
Annals of neurology 62 (4), 406-413, 2007
5002007
Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: phase 3 study
O Sabri, MN Sabbagh, J Seibyl, H Barthel, H Akatsu, Y Ouchi, K Senda, ...
Alzheimer's & dementia 11 (8), 964-974, 2015
4912015
Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression
M Shi, J Bradner, AM Hancock, KA Chung, JF Quinn, ER Peskind, ...
Annals of neurology 69 (3), 570-580, 2011
4742011
Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders
F Abdi, JF Quinn, J Jankovic, M McIntosh, JB Leverenz, E Peskind, ...
Journal of Alzheimer's Disease 9 (3), 293-348, 2006
4682006
Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-ε4 allele
DG Cook, JB Leverenz, PJ McMillan, JJ Kulstad, S Ericksen, RA Roth, ...
The American journal of pathology 162 (1), 313-319, 2003
4682003
Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases
H Nakashima-Yasuda, K Uryu, J Robinson, SX Xie, H Hurtig, JE Duda, ...
Acta neuropathologica 114, 221-229, 2007
4632007
The system can't perform the operation now. Try again later.
Articles 1–20